The Company has agreed in the Equity Distribution Agreement to provide indemnification and contribution to the Agent against certain liabilities, including liabilities under the Securities Act of 193…
Aardvark Therapeutics, Inc. Customers
No clients on recordNo downstream customers found in our database for Aardvark Therapeutics, Inc..
Aardvark Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
AARD-DEBT-7408
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
AARD-DEBT
Debt stack $336,000
90%
Market cache reports total debt of $336,000.
Aardvark Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Aardvark Therapeutics, Inc..
Aardvark Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
AARD-OWNER-DECHENG-CAPITAL-LLC
Decheng Capital LLC
90%
13F overlay lists Decheng Capital LLC as top holder; 80 tracked holders.
Aardvark Therapeutics, Inc. Extended Supply Chain Network